COX2 - cytochrome c oxidase subunit II Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 2846628
COX2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| YP_026107.1 cytochrome c oxidase subunit II (mitochondrion) [Macaca mulatta] |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cytochrome c oxidase subunit II |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(100)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-66005 | Acetaminophen | 99.97% | Unkown | |
| HY-B0075 | Melatonin | 99.93% | Yes | |
| HY-14397 | Indomethacin | Inhibitor | 99.90% | Yes |
| HY-14398 | Celecoxib | Inhibitor | 99.89% | Yes |
| HY-14654 | Aspirin | 99.90% | Yes | |
| HY-N0523 | Gallic acid | 99.99% | Unkown | |
| HY-15036 | Diclofenac | 99.92% | Yes | |
| HY-N0603 | 20(S)-Ginsenoside Rg3 | Inhibitor | 99.82% | Unkown |
| HY-B0261 | Meloxicam | 99.59% | Yes | |
| HY-15030 | Naproxen | 99.98% | Yes | |
| HY-15037 | Diclofenac Sodium | 99.81% | Yes | |
| HY-B0167 | Salicylic acid | 98.65% | Yes | |
| HY-B0227 | Ketoprofen | Inhibitor | 99.95% | Yes |
| HY-B0360 | Rebamipide | Activator | 99.74% | Yes |
| HY-B1227 | Carprofen | Inhibitor | 99.94% | Unkown |
| HY-B0084 | Dienogest | Agonist | 99.93% | Unkown |
| HY-78131A | (S)-(+)-Ibuprofen | Inhibitor | 99.98% | Unkown |
| HY-B0464 | Hydralazine hydrochloride | Inhibitor | 99.97% | Yes |
| HY-B0167A | Sodium Salicylate | 99.99% | Yes | |
| HY-15762 | Valdecoxib | Inhibitor | 99.89% | Yes |
| HY-17009 | Iguratimod | Inhibitor | 98.49% | Yes |
| HY-B0253 | Piroxicam | Inhibitor | 99.78% | Unkown |
| HY-B0493 | Niflumic acid | Inhibitor | 99.61% | Unkown |
| HY-N1380 | Guaiacol | Inhibitor | 99.96% | Unkown |
| HY-14397A | Indomethacin sodium hydrate | Inhibitor | 99.85% | Yes |
| HY-B0363 | Nimesulide | Inhibitor | 99.89% | Yes |
| HY-17372 | Rofecoxib | Inhibitor | 99.89% | Yes |
| HY-108775A | Sodium thiosulfate (99%, water≤1.0%) | Inhibitor | 99.89% | Unkown |
| HY-B0808 | Oxaprozin | 99.94% | Unkown | |
| HY-B0760 | Fenofibric acid | 99.94% | Unkown | |
| HY-15030A | Naproxen sodium | 99.74% | Yes | |
| HY-15321 | Etoricoxib | Inhibitor | 99.91% | Yes |
| HY-17474 | Parecoxib | Inhibitor | 99.29% | Yes |
| HY-B0335 | Tolfenamic Acid | Inhibitor | 99.94% | Yes |
| HY-B0580 | Ketorolac | 99.87% | Yes | |
| HY-B1114 | Gliquidone | Inhibitor | 99.93% | Unkown |
| HY-13507 | Lumiracoxib | Inhibitor | 99.93% | Yes |
| HY-B1153 | Glafenine | 98.77% | Unkown | |
| HY-B0559 | Nabumetone | Inhibitor | 99.94% | Yes |
| HY-B2137 | S-(+)-Ketoprofen | Inhibitor | 99.88% | Unkown |
| HY-N0523R | Gallic acid (Standard) | 99.81% | Unkown | |
| HY-17474A | Parecoxib Sodium | Inhibitor | 99.82% | Yes |
| HY-W015007 | Metyrosine | Inhibitor | 99.64% | Unkown |
| HY-B0138 | Ketorolac tromethamine salt | Inhibitor | 99.53% | Yes |
| HY-B0367 | Lornoxicam | 99.36% | Unkown | |
| HY-B0736A | Sertaconazole nitrate | 99.19% | Unkown | |
| HY-B1153A | Glafenine hydrochloride | 99.03% | Unkown | |
| HY-B0336 | Pranoprofen | 98.56% | Unkown | |
| HY-B0167R | Salicylic acid (Standard) | 98.00% | Unkown | |
| HY-B1799 | Tolmetin | Inhibitor | 99.54% | Unkown |
| HY-B0578 | Loxoprofen | Inhibitor | 99.57% | Yes |
| HY-114200 | Imrecoxib | Inhibitor | 99.48% | Yes |
| HY-17509 | Deracoxib | 99.96% | Unkown | |
| HY-N0523A | Gallic acid hydrate | 99.98% | Unkown | |
| HY-B0619 | Zaltoprofen | Inhibitor | 98.89% | Unkown |
| HY-120824 | Mofezolac | Inhibitor | 99.34% | Unkown |
| HY-N7067 | Revaprazan hydrochloride | Inhibitor | 99.98% | Unkown |
| HY-15030R | Naproxen (Standard) | 99.91% | Unkown | |
| HY-B0464A | Hydralazine | Inhibitor | 99.94% | Yes |
| HY-B1888A | Bromfenac sodium | Inhibitor | 99.92% | Unkown |
| HY-B1888B | Bromfenac sodium hydrate | Inhibitor | 99.94% | Unkown |
| HY-15037R | Diclofenac Sodium (Standard) | 99.96% | Unkown | |
| HY-108775 | Sodium thiosulfate (98%) | Inhibitor | 98.30% | Yes |
| HY-15038 | Diclofenac potassium | 99.85% | Yes | |
| HY-12383 | Pelubiprofen | Inhibitor | 98.46% | Yes |
| HY-17357 | Nepafenac | Inhibitor | 99.56% | Unkown |
| HY-B0261R | Meloxicam (Standard) | 99.89% | Unkown | |
| HY-B1138 | Fenbufen | Inhibitor | 98.50% | Unkown |
| HY-B0641 | Felbinac | Inhibitor | 99.94% | Unkown |
| HY-15036A | Diclofenac diethylamine | 99.95% | Yes | |
| HY-B0578A | Loxoprofen sodium | Inhibitor | 99.63% | Yes |
| HY-100009 | Ufenamate | Inhibitor | 99.89% | Unkown |
| HY-14398R | Celecoxib (Standard) | Inhibitor | 99.97% | Unkown |
| HY-B0493R | Niflumic acid (Standard) | Inhibitor | 99.93% | Unkown |
| HY-N1380R | Guaiacol (Standard) | Inhibitor | 99.70% | Unkown |
| HY-B1489 | Tolmetin sodium dihydrate | Inhibitor | 99.94% | Unkown |
| HY-16726 | Polmacoxib | Inhibitor | 99.70% | Unkown |
| HY-B1153R | Glafenine (Standard) | 98.59% | Unkown | |
| HY-17479A | Amfenac Sodium Hydrate | Inhibitor | 98.33% | Unkown |
| HY-66004 | 4-Acetamidophenyl acetate | 97.0% | Yes | |
| HY-B0335R | Tolfenamic Acid (Standard) | Inhibitor | 99.97% | Unkown |
| HY-B1130 | Isoxicam | Inhibitor | 99.83% | Unkown |
| HY-B0227A | Ketoprofen (lysinate) | Inhibitor | / | Unkown |
| HY-121851 | Revaprazan | Inhibitor | / | Unkown |
| HY-14654A | Aspirin lithium | / | Unkown | |
| HY-15034 | Indomethacin sodium | Inhibitor | / | Unkown |
| HY-B0580C | Ketorolac hemicalcium | 98.06% | Yes | |
| HY-121046 | Flunixin | Inhibitor | / | Unkown |
| HY-15030AR | Naproxen sodium (Standard) | / | Unkown | |
| HY-15321R | Etoricoxib (Standard) | Inhibitor | 99.92% | Unkown |
| HY-66004R | 4-Acetamidophenyl acetate (Standard) | / | Unkown | |
| HY-B0227R | Ketoprofen (Standard) | Inhibitor | / | Unkown |
| HY-B0261A | Meloxicam sodium | / | Unkown | |
| HY-B0578B | Loxoprofen sodium dihydrate | Inhibitor | / | Unkown |
| HY-B0736 | Sertaconazole | 99.42% | Unkown | |
| HY-B0808A | Oxaprozin potassium | / | Unkown | |
| HY-B0808R | Oxaprozin (Standard) | / | Unkown | |
| HY-B1799A | Tolmetin sodium | Inhibitor | / | Unkown |
| HY-B1888 | Bromfenac | Inhibitor | / | Unkown |
| HY-N0603R | 20(S)-Ginsenoside Rg3 (Standard) | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(20)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-14654C | Aspirin calcium | / | Phase 4 | |
| HY-B1773A | Sodium propionate | 99.0% | Phase 3 | |
| HY-15123 | (S)-Flurbiprofen | Inhibitor | 99.88% | Phase 3 |
| HY-B1026 | Adelmidrol | 98.0% | Phase 3 | |
| HY-19675 | Naproxen etemesil | Inhibitor | 99.89% | Phase 3 |
| HY-N1067 | Xanthohumol | 99.94% | Phase 2 | |
| HY-14445 | FK 3311 | Inhibitor | 98.72% | Phase 2 |
| HY-100516 | Cimicoxib | Inhibitor | 98.02% | Phase 2 |
| HY-14783 | Apricoxib | Inhibitor | 98.84% | Phase 2 |
| HY-119348 | Nitroparacetamol | Inhibitor | / | Phase 2 |
| HY-155031 | MCI | Inhibitor | / | Phase 2 |
| HY-177643 | Lixadesiran | Inhibitor | / | Phase 2 |
| HY-177643A | Lixadesiran sodium | Inhibitor | / | Phase 2 |
| HY-177657 | Pixofisiran | Inhibitor | / | Phase 2 |
| HY-177657A | Pixofisiran sodium | Inhibitor | / | Phase 2 |
| HY-19500 | SC-75416 | Inhibitor | / | Phase 2 |
| HY-19212 | S-2474 | Inhibitor | / | Phase 2 |
| HY-19384 | Enflicoxib | Inhibitor | 99.88% | Phase 1 |
| HY-13692 | 1α-Hydroxyvitamin D5 | / | Phase 1 | |
| HY-106897 | BF389 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(636)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B1081A | Oxidopamine hydrobromide | 99.42% | Unkown | |
| HY-B1081 | Oxidopamine hydrochloride | 99.91% | Unkown | |
| HY-N7038 | Phytohemagglutinin | 80.00% | Unkown | |
| HY-N0028 | Forsythiaside A | 99.79% | Unkown | |
| HY-N0256 | Hederagenin | 99.95% | Unkown | |
| HY-13913 | NS-398 | Inhibitor | 99.71% | Unkown |
| HY-W251428 | Phosphatidylglycerols (egg) sodium salt | 99.53% | Unkown | |
| HY-N0904 | Ginsenoside C-K | Inhibitor | 99.93% | Unkown |
| HY-111310 | ML351 | Inhibitor | 99.16% | Unkown |
| HY-14654R | Aspirin (Standard) | 99.92% | Unkown | |
| HY-N0722 | Neochlorogenic acid | Inhibitor | 99.80% | Unkown |
| HY-N1435 | Oroxin B | 99.39% | Unkown | |
| HY-N0767 | Isoorientin | Inhibitor | 98.36% | Unkown |
| HY-13425 | Deguelin | 99.20% | Unkown | |
| HY-148013 | K284-6111 | Inhibitor | 99.94% | Unkown |
| HY-N0147 | Rutaecarpine | 99.77% | Unkown | |
| HY-N0279 | Cardamonin | 99.80% | Unkown | |
| HY-N0103 | Sophocarpine | 99.85% | Unkown | |
| HY-N2072 | Crocetin | Inhibitor | 98.07% | Unkown |
| HY-114360 | Taurohyodeoxycholic acid | Inhibitor | 99.73% | Unkown |
| HY-N0569 | Madecassic acid | Inhibitor | 99.93% | Unkown |
| HY-N0043 | Ginsenoside Rd | Inhibitor | 99.88% | Unkown |
| HY-78131S | Ibuprofen-d3 | 99.94% | Unkown | |
| HY-170621 | STAT1/3-IN-1 | Inhibitor | 99.23% | Unkown |
| HY-N0232 | Psoralidin | 99.90% | Unkown | |
| HY-N1957 | Gamma-Mangostin | 99.91% | Unkown | |
| HY-N6966 | Ethyl Caffeate | Inhibitor | 99.34% | Unkown |
| HY-N0774 | Isofraxidin | Inhibitor | 99.94% | Unkown |
| HY-N2176 | S-(+)-Marmesin | Inhibitor | 99.9% | Unkown |
| HY-N1390 | Syringaldehyde | Inhibitor | 99.96% | Unkown |
| HY-N6607 | Tryptanthrin | 99.89% | Unkown | |
| HY-N6968 | α-Humulene | Inhibitor | 98.55% | Unkown |
| HY-N0493 | Pectolinarigenin | 99.98% | Unkown | |
| HY-N0831 | Jaceosidin | 99.51% | Unkown | |
| HY-Y1100 | Cyclopropylmethyl bromide | 99.26% | Unkown | |
| HY-B0167S | Salicylic acid-d6 | 99.82% | Unkown | |
| HY-N0481 | Roburic acid | 99.93% | Unkown | |
| HY-N0635 | Prim-O-glucosylcimifugin | Inhibitor | 99.87% | Unkown |
| HY-N0710 | alpha-Cyperone | 99.68% | Unkown | |
| HY-N7700A | Guluronic acid sodium | Inhibitor | 98.0% | Unkown |
| HY-N1312 | Sinapaldehyde | Inhibitor | 99.71% | Unkown |
| HY-14617 | Paradol | Inhibitor | 98.66% | Unkown |
| HY-N0447 | 8-Gingerol | 99.82% | Unkown | |
| HY-N0762 | Isobavachin | 99.88% | Unkown | |
| HY-P1633 | Protegrin-1 | 99.87% | Unkown | |
| HY-66005S | Acetaminophen-d4 | Inhibitor | 99.60% | Unkown |
| HY-W109812 | Sinapyl alcohol | 99.62% | Unkown | |
| HY-N0908 | Ginsenoside Rg5 | 99.88% | Unkown | |
| HY-66005R | Acetaminophen (Standard) | Inhibitor | 99.97% | Unkown |
| HY-N0041 | Ginsenoside Rb3 | Inhibitor | 99.87% | Unkown |
| HY-N0396 | Harpagoside | Inhibitor | 99.88% | Unkown |
| HY-N0222 | Avicularin | 99.80% | Unkown | |
| HY-N0589 | Dehydrodiisoeugenol | 99.98% | Unkown | |
| HY-N7108 | 7-Hydroxyflavone | 99.89% | Unkown | |
| HY-B0075S | Melatonin-d4 | 99.70% | Unkown | |
| HY-N0616 | Trifolirhizin | 98.37% | Unkown | |
| HY-N2392 | Kukoamine A | 99.88% | Unkown | |
| HY-W040045 | Callistephin chloride | Inhibitor | 98.31% | Unkown |
| HY-N0818 | Chikusetsusaponin Iva | Inhibitor | 99.61% | Unkown |
| HY-108259 | HQL-79 | Inhibitor | 99.89% | Unkown |
| HY-132184 | 5,6-Epoxyeicosatrienoic acid | Inhibitor | 99.9% | Unkown |
| HY-N2435 | [8]-Shogaol | 99.93% | Unkown | |
| HY-N5015 | Rosmanol | Inhibitor | 98.95% | Unkown |
| HY-W018643 | Ferulic acid methyl ester | Inhibitor | 99.95% | Unkown |
| HY-B0075S1 | Melatonin-d3 | 99.15% | Unkown | |
| HY-N0735 | Phellodendrine chloride | 99.68% | Unkown | |
| HY-N0632 | Esculentoside A | Inhibitor | 99.89% | Unkown |
| HY-N2007 | Veratric acid | Inhibitor | 99.99% | Unkown |
| HY-P1938 | Cyclo(L-Pro-L-Val) | Inhibitor | 98.14% | Unkown |
| HY-B0075R | Melatonin (standard) | 99.27% | Unkown | |
| HY-N0356 | (-)-Catechin gallate | Inhibitor | 99.98% | Unkown |
| HY-N0613 | Sauchinone | Inhibitor | 99.62% | Unkown |
| HY-N1508 | Ecliptasaponin A | 99.81% | Unkown | |
| HY-N2434 | [10]-Shogaol | Inhibitor | 99.78% | Unkown |
| HY-N6084 | Humulone | 99.46% | Unkown | |
| HY-W1000105 | Geranial | 99.51% | Unkown | |
| HY-103387 | DuP-697 | 99.79% | Unkown | |
| HY-113083 | Acetaminophen glucuronide | 99.96% | Unkown | |
| HY-14654S | Aspirin-d3 | 99.84% | Unkown | |
| HY-N0894 | Octahydrocurcumin | 99.25% | Unkown | |
| HY-N0929 | Hexahydrocurcumin | Inhibitor | 99.70% | Unkown |
| HY-W010983 | SC-236 | 99.59% | Unkown | |
| HY-N0523S | Gallic acid-d2 | 99.59% | Unkown | |
| HY-128463 | N-tert-Butyl-α-phenylnitrone | Inhibitor | 99.94% | Unkown |
| HY-N0631 | Cornuside | Inhibitor | 99.99% | Unkown |
| HY-N7688 | Regaloside B | Inhibitor | 99.90% | Unkown |
| HY-W031757 | Anthraquinone-2-carboxylic acid | Inhibitor | 98.0% | Unkown |
| HY-B0386 | Flunixin meglumine | Inhibitor | 99.65% | Unkown |
| HY-N1380S1 | Guaiacol-d3 | Inhibitor | 99.0% | Unkown |
| HY-N0896 | Inulicin | Inhibitor | 99.94% | Unkown |
| HY-147972 | NF-κB/MAPK-IN-1 | Inhibitor | 98.71% | Unkown |
| HY-N2454 | β-Elemonic acid | 99.77% | Unkown | |
| HY-D0053 | 6-ROX | 98.43% | Unkown | |
| HY-N1921 | Edpetiline | Inhibitor | 99.81% | Unkown |
| HY-W010995 | 2,5-Dimethylcelecoxib | Inhibitor | 99.57% | Unkown |
| HY-W010037 | 2-(tert-Butyl)-4-methoxyphenol | Inhibitor | 99.86% | Unkown |
| HY-129440 | N-(p-Coumaroyl) Serotonin | 99.03% | Unkown | |
| HY-133159 | Resolvin E2 | 98.5% | Unkown | |
| HY-B0580A | (S)-Ketorolac | Inhibitor | 99.27% | Unkown |
| HY-N0103A | Sophocarpine monohydrate | 99.91% | Unkown | |
| HY-N0167 | Gynostemma Extract | Inhibitor | 99.92% | Unkown |
| HY-N0920 | Dihydrokavain | Inhibitor | 99.94% | Unkown |
| HY-W007539 | 2,4-Dihydroxybenzaldehyde | Inhibitor | 99.93% | Unkown |
| HY-W010066 | 3,4-Dihydroxyphenylglycol | 98.07% | Unkown | |
| HY-W086896 | α-Demethylnaproxen | 99.76% | Unkown | |
| HY-100580 | Asaraldehyde | Inhibitor | 99.42% | Unkown |
| HY-10439 | HPGDS inhibitor 1 | Inhibitor | 99.42% | Unkown |
| HY-15029 | (±)-Naproxen | Inhibitor | 99.94% | Unkown |
| HY-G0007 | Omeprazole sulfone | Control | 99.23% | Unkown |
| HY-N0074 | Byakangelicol | Inhibitor | 99.48% | Unkown |
| HY-N0864 | Macranthoidin B | 98.35% | Unkown | |
| HY-N5083 | Saponarin | 99.95% | Unkown | |
| HY-N6962 | α-Spinasterol | 99.90% | Unkown | |
| HY-P10710A | BMP-4 (15-24) acetate | Inhibitor | 99.30% | Unkown |
| HY-126848 | Diclofenac acyl glucuronide | 98.34% | Unkown | |
| HY-W324435 | 2,4-Dinitrobenzenesulfonic acid sodium salt | Activator | 99.98% | Unkown |
| HY-W012399 | 2,5-Di-tert-butylhydroquinone | 99.73% | Unkown | |
| HY-W012817 | Methylhydroquinone | Inhibitor | 99.91% | Unkown |
| HY-122591 | PTUPB | Inhibitor | 98.05% | Unkown |
| HY-14654S1 | Aspirin-d4 | 98.41% | Unkown | |
| HY-66005S2 | Acetaminophen-d7 | 99.92% | Unkown | |
| HY-N12586 | Pheophytin a | 80.0% | Unkown | |
| HY-N6079 | Timosaponin A1 | Inhibitor | 99.70% | Unkown |
| HY-W011849 | Phenyl β-D-glucopyranoside | Inhibitor | 99.85% | Unkown |
| HY-B1773AS3 | Sodium propionate-13C3 | 99.45% | Unkown | |
| HY-15036S | Diclofenac-d4 | 99.79% | Unkown | |
| HY-107208 | Procyanidol B4 | Inhibitor | 99.99% | Unkown |
| HY-121537 | CAY10404 | 99.40% | Unkown | |
| HY-129113 | α-Chaconine | Inhibitor | 99.76% | Unkown |
| HY-15037S1 | Diclofenac-d4 sodium | 99.49% | Unkown | |
| HY-N0346A | (E)-Ethyl p-methoxycinnamate | 99.39% | Unkown | |
| HY-N1942 | 5-O-Demethylnobiletin | Inhibitor | 99.91% | Unkown |
| HY-N4288 | 4-Methylesculetin | Inhibitor | 99.27% | Unkown |
| HY-NP192 | Sericin | 0% | Unkown | |
| HY-W013164 | SC-58125 | Inhibitor | 99.92% | Unkown |
| HY-W923189 | Neral | 97.87% | Unkown | |
| HY-B0075S2 | Melatonin-d7 | 98.85% | Unkown | |
| HY-113463 | Cholesteryl eicosapentaenoate | Inhibitor | 99.9% | Unkown |
| HY-114950 | EXP3179 | Inhibitor | 98.09% | Unkown |
| HY-136477 | Pentagamavunon-1 | 98.95% | Unkown | |
| HY-17485 | Alminoprofen | Inhibitor | 99.91% | Unkown |
| HY-B0261S | Meloxicam-d3 | 99.55% | Unkown | |
| HY-B0760R | Fenofibric acid (Standard) | 99.57% | Unkown | |
| HY-N0389 | Columbin | Inhibitor | 99.80% | Unkown |
| HY-N0887 | Isoastragaloside I | 99.49% | Unkown | |
| HY-N12717 | Casuarinin | 98.24% | Unkown | |
| HY-N2429 | Sphondin | Inhibitor | 99.70% | Unkown |
| HY-N6028 | Darutoside | Inhibitor | 99.89% | Unkown |
| HY-N7064 | Iminostilbene | Inhibitor | 99.34% | Unkown |
| HY-14670 | Firocoxib | Inhibitor | 99.54% | Unkown |
| HY-108297 | Piketoprofen | 99.54% | Unkown | |
| HY-A0259 | Floctafenine | Inhibitor | 95.28% | Unkown |
| HY-B0227S | Ketoprofen-d3 | 99.8% | Unkown | |
| HY-N0569R | Madecassic acid (Standard) | Inhibitor | 99.91% | Unkown |
| HY-N2252 | Licarin A | Inhibitor | 99.83% | Unkown |
| HY-N2925 | β-Amyrone | Inhibitor | 99.87% | Unkown |
| HY-165131 | Δ7-Avenasterol | 95.0% | Unkown | |
| HY-66005S4 | Acetaminophen-13C2,15N | 98.30% | Unkown | |
| HY-N0854 | Alisol F | Inhibitor | 99.89% | Unkown |
| HY-N10303 | Withangulatin A | 99.76% | Unkown | |
| HY-N2106 | Dehydroevodiamine | Inhibitor | 98.55% | Unkown |
| HY-W039699 | 2-(p-Tolyl)propanoic acid | Inhibitor | / | Unkown |
| HY-107260 | Lucidenic acid D | 99.78% | Unkown | |
| HY-118816 | 11β-Prostaglandin F2α | 95.0% | Unkown | |
| HY-121811 | Pongamol | 99.81% | Unkown | |
| HY-124481 | Oleocanthal | ≥99.0% | Unkown | |
| HY-131258 | Ibuprofen impurity 1 | Inhibitor | 98.0% | Unkown |
| HY-131259 | Ibuprofen Impurity F | Inhibitor | 97.56% | Unkown |
| HY-15321S | Etoricoxib-d4 | 98.82% | Unkown | |
| HY-172920 | Wnt/β-catenin-IN-6 | 98.34% | Unkown | |
| HY-B0580S | Ketorolac-d5 | Inhibitor | 98.75% | Unkown |
| HY-B1773AS | Sodium propionate-13C | 99.6% | Unkown | |
| HY-N0761A | trans-Isoferulic acid | 99.93% | Unkown | |
| HY-N2008 | Luteolin 5-O-glucoside | Inhibitor | ≥98.0% | Unkown |
| HY-N8184 | 4,4'-Dihydroxy-2,6-dimethoxydihydrochalcone | Inhibitor | 99.64% | Unkown |
| HY-RS11393 | PTGS2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W012126 | 2,6-Dichlorodiphenylamine | Inhibitor | 99.78% | Unkown |
| HY-W016183 | 2,2'-Biphenol | Inhibitor | / | Unkown |
| HY-W419589 | Xanthomicrol | 97.68% | Unkown | |
| HY-114911 | Feprazone | Inhibitor | 99.88% | Unkown |
| HY-118078 | Robenacoxib | Inhibitor | 98.08% | Unkown |
| HY-B2121 | 6-Methoxy-2-naphthoic acid | Inhibitor | 99.73% | Unkown |
| HY-N6663 | 3-Carene | Inhibitor | 91.66% | Unkown |
| HY-N8167 | Plantanone B | Inhibitor | 99.16% | Unkown |
| HY-W414731 | N-(3-Methylphenyl)anthranilic acid | 99.82% | Unkown | |
| HY-B0464S1 | Hydralazine-d5 hydrochloride | Inhibitor | 99.9% | Unkown |
| HY-14398S | Celecoxib-d7 | Inhibitor | 99.58% | Unkown |
| HY-B0559S | Nabumetone-d3 | Inhibitor | 98.80% | Unkown |
| HY-115770 | 8-Methylsulfinyloctyl isothiocyanate | 99.72% | Unkown | |
| HY-118139 | Desmethyl Celecoxib | Inhibitor | 99.42% | Unkown |
| HY-119671 | BW 755C | Inhibitor | 95.0% | Unkown |
| HY-129284 | APHS | Inhibitor | 99.0% | Unkown |
| HY-134234 | Celecoxib carboxylic acid | Inhibitor | 98.28% | Unkown |
| HY-14398S1 | Celecoxib-d3 | Inhibitor | 99.0% | Unkown |
| HY-14837 | Amizon | Inhibitor | 99.92% | Unkown |
| HY-15036S1 | Diclofenac-13C6 | 99.90% | Unkown | |
| HY-171657 | 4'-Acetoxy resveratrol | 99.90% | Unkown | |
| HY-66005S1 | Acetaminophen-d3 | Inhibitor | 99.97% | Unkown |
| HY-N0427 | Phellodendrine | 99.60% | Unkown | |
| HY-N8371 | Shizukaol B | Inhibitor | 96.0% | Unkown |
| HY-RS08758 | MT-CO2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-113509B | 15(R)-Lipoxin A4 | 98.3% | Unkown | |
| HY-N16129 | Diplacone | 98.38% | Unkown | |
| HY-N8693 | Withanoside IV | 98.47% | Unkown | |
| HY-W026930 | Benzanthrone | 99.69% | Unkown | |
| HY-W028263 | 6-Hydroxyflavanone | Inhibitor | 99.87% | Unkown |
| HY-W196368 | Thymohydroquinone | Inhibitor | 99.91% | Unkown |
| HY-139578 | Ocarocoxib | Inhibitor | 99.94% | Unkown |
| HY-106823 | Tebufelone | Inhibitor | 99.52% | Unkown |
| HY-109158 | Rebamipide mofetil | Inhibitor | 96.12% | Unkown |
| HY-119447 | Mavacoxib | Inhibitor | 99.04% | Unkown |
| HY-121996 | Prostaglandin E2 Ethanolamide | / | Unkown | |
| HY-134753 | Teriflunomide impurity 3 | Inhibitor | 99.75% | Unkown |
| HY-134996 | N-Acetyl-2-carboxybenzenesulfonamide | Inhibitor | 98.09% | Unkown |
| HY-135325 | 4-Hydroxyacetophenone oxime | 99.96% | Unkown | |
| HY-136592 | 1-Hydroxy-ibuprofen | Inhibitor | / | Unkown |
| HY-137011 | 3,9-Dihydroeucomin | Inhibitor | 97.0% | Unkown |
| HY-14397S | Indomethacin-d4 | Inhibitor | 99.78% | Unkown |
| HY-146564 | R-HP210 | 98.21% | Unkown | |
| HY-15037S2 | Diclofenac-13C6 sodium | 99.96% | Unkown | |
| HY-17357S | Nepafenac-d5 | Inhibitor | 98.84% | Unkown |
| HY-78131AS | (S)-(+)-Ibuprofen-d3 | Inhibitor | 99.96% | Unkown |
| HY-B0008S | Sulindac-d3 | 99.4% | Unkown | |
| HY-B0167S1 | Salicylic acid-13C6 | 97.0% | Unkown | |
| HY-B0253S | Piroxicam-d3 | Inhibitor | 99.68% | Unkown |
| HY-B0261S2 | Meloxicam-13C,d3 | ≥99.90% | Unkown | |
| HY-B0261S4 | Meloxicam-13C6 | / | Unkown | |
| HY-B0464S | Hydralazine-d4 hydrochloride | Inhibitor | / | Unkown |
| HY-N0811 | Anemarsaponin B | Inhibitor | 99.43% | Unkown |
| HY-N1965 | Gaultherin | Inhibitor | 99.44% | Unkown |
| HY-N4226 | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | Inhibitor | 99.94% | Unkown |
| HY-N6891 | Hamaudol | Inhibitor | 99.98% | Unkown |
| HY-N7630 | Rehmapicrogenin | Inhibitor | / | Unkown |
| HY-N7700 | Guluronic acid | Inhibitor | 98.90% | Unkown |
| HY-N8413 | Chlojaponilactone B | Inhibitor | 98.0% | Unkown |
| HY-B0578S | Loxoprofen-d4 | Inhibitor | 99.04% | Unkown |
| HY-B1773AS4 | Sodium propionate-d5 | 99.91% | Unkown | |
| HY-B1773AS5 | Sodium propionate-d3 | 98.38% | Unkown | |
| HY-N11011 | Withaphysalin A | Inhibitor | 98% | Unkown |
| HY-N6966A | Ethyl trans-caffeate | 98.0% | Unkown | |
| HY-N9454 | Garcinoic acid | / | Unkown | |
| HY-U00022 | RWJ 63556 | Inhibitor | 99.35% | Unkown |
| HY-U00046 | Apyramide | Inhibitor | 99.06% | Unkown |
| HY-U00129 | SC57666 | Inhibitor | 98.94% | Unkown |
| HY-U00146 | FR-188582 | Inhibitor | 99.12% | Unkown |
| HY-W109812S | Sinapyl alcohol-d3 | 76.50% | Unkown | |
| HY-115866 | COX-2-IN-6 | Inhibitor | 98.80% | Unkown |
| HY-15321S2 | Etoricoxib-d3 | / | Unkown | |
| HY-14398GL | Celecoxib (GMP Like) | Inhibitor | / | Unkown |
| HY-118139S | Celecoxib-d4 | Inhibitor | / | Unkown |
| HY-126121S | 2-Hydroxy Ibuprofen-d6 | Inhibitor | / | Unkown |
| HY-14397S1 | Indomethacin-d4 Methyl Ester | Inhibitor | 98.38% | Unkown |
| HY-15762S | Valdecoxib-d3 | Inhibitor | / | Unkown |
| HY-B0367S | Lornoxicam-d4 | Inhibitor | / | Unkown |
| HY-105028S | Tenidap-d3 | Inhibitor | / | Unkown |
| HY-105290 | DRF-4848 | Inhibitor | / | Unkown |
| HY-106093 | Eltenac | Inhibitor | / | Unkown |
| HY-108019 | SD 8381 | Inhibitor | / | Unkown |
| HY-108162A | Ataquimast | Inhibitor | / | Unkown |
| HY-111274 | Indomethacin farnesil | Inhibitor | 97.29% | Unkown |
| HY-111950 | (-)-Ibuprofenamide | Inhibitor | / | Unkown |
| HY-113264 | PGD2 ethanolamide | Inducer | / | Unkown |
| HY-114200S | Imrecoxib-d7 | Inhibitor | / | Unkown |
| HY-114795 | Indomethacin heptyl ester | Inhibitor | / | Unkown |
| HY-114796 | tHGA | Inhibitor | / | Unkown |
| HY-115920 | Anti-inflammatory agent 8 | / | Unkown | |
| HY-115921 | Anti-inflammatory agent 9 | / | Unkown | |
| HY-115922 | Anti-inflammatory agent 10 | / | Unkown | |
| HY-115934 | COX-2-IN-7 | Inhibitor | / | Unkown |
| HY-115935 | COX-2-IN-8 | Inhibitor | / | Unkown |
| HY-115936 | COX-2-IN-9 | / | Unkown | |
| HY-115966 | COX-1/2-IN-1 | Inhibitor | / | Unkown |
| HY-115967 | COX-1/2-IN-2 | Inhibitor | / | Unkown |
| HY-115976 | COX-2-IN-10 | Inhibitor | / | Unkown |
| HY-116243 | Vitacoxib | Inhibitor | / | Unkown |
| HY-116610 | L 748780 | Inhibitor | / | Unkown |
| HY-116763 | COX-2/5-LOX-IN-4 | Inhibitor | / | Unkown |
| HY-116811 | AZ-11665362 | / | Unkown | |
| HY-116877 | C2 Ceramide (d14:1/2:0) | / | Unkown | |
| HY-116947 | COX-2-IN-5 | Inhibitor | / | Unkown |
| HY-118506 | BRP-7 | Inhibitor | / | Unkown |
| HY-119447S | Mavacoxib-d4 | Inhibitor | / | Unkown |
| HY-121357 | Lefucoxib | Inhibitor | / | Unkown |
| HY-121679 | COX-2-IN-50 | Inhibitor | / | Unkown |
| HY-121828 | TX-1123 | Inhibitor | / | Unkown |
| HY-121899 | 1-Oxo Ibuprofen | / | Unkown | |
| HY-12292G | IM-12 (GMP) | / | Unkown | |
| HY-123639 | LM-4108 | Inhibitor | / | Unkown |
| HY-12383S | Pelubiprofen-13C,d3 | Inhibitor | / | Unkown |
| HY-126121 | 2-Hydroxy Ibuprofen | Inhibitor | / | Unkown |
| HY-127145 | Parsalmide | Inhibitor | / | Unkown |
| HY-128463S | N-tert-Butyl-α-phenylnitrone-d14 | / | Unkown | |
| HY-130314 | PPHP | / | Unkown | |
| HY-131260 | Ibuprofen Impurity K | Inhibitor | / | Unkown |
| HY-135081 | N-(4-acetamidophenyl)-Indomethacin amide | Inhibitor | / | Unkown |
| HY-137957 | Longiferone B | Inhibitor | / | Unkown |
| HY-138101 | Desmethyl etoricoxib | Inhibitor | 99.64% | Unkown |
| HY-14397G | Indomethacin (GMP) | Inhibitor | / | Unkown |
| HY-14398G | Celecoxib (GMP) | Inhibitor | / | Unkown |
| HY-145988 | COX-2-IN-11 | Inhibitor | / | Unkown |
| HY-146161 | COX-2/NO-IN-1 | Inhibitor | / | Unkown |
| HY-146198 | COX-2-IN-19 | Inhibitor | / | Unkown |
| HY-146294 | COX-2/5-LOX-IN-1 | Inhibitor | / | Unkown |
| HY-146295 | COX-2/5-LOX-IN-2 | / | Unkown | |
| HY-146370 | COX-2-IN-12 | Inhibitor | / | Unkown |
| HY-146371 | COX-2-IN-13 | Inhibitor | / | Unkown |
| HY-146419 | Anti-inflammatory agent 20 | Inhibitor | / | Unkown |
| HY-146561 | S-HP210 | Modulator | 98.12% | Unkown |
| HY-146704 | COX-2/sEH-IN-1 | Inhibitor | / | Unkown |
| HY-14670R | Firocoxib (Standard) | Inhibitor | / | Unkown |
| HY-147692 | COX-2-IN-14 | Inhibitor | / | Unkown |
| HY-147693 | COX-1/2-IN-3 | Inhibitor | / | Unkown |
| HY-147719 | COX-2-IN-16 | Inhibitor | / | Unkown |
| HY-147748 | COX-2-IN-17 | Inhibitor | / | Unkown |
| HY-147770 | NF-κB-IN-6 | Inhibitor | / | Unkown |
| HY-147794 | CDK9-IN-41 | Inhibitor | 98.84% | Unkown |
| HY-147809 | COX-2-IN-20 | Inhibitor | / | Unkown |
| HY-147815 | COX-2-IN-21 | Inhibitor | / | Unkown |
| HY-147870 | COX-2-IN-22 | Inhibitor | / | Unkown |
| HY-147911 | COX-2/PI3K-IN-1 | Inhibitor | / | Unkown |
| HY-147912 | COX-2/PI3K-IN-2 | Inhibitor | / | Unkown |
| HY-147951 | COX-2/5-LOX-IN-3 | Inhibitor | / | Unkown |
| HY-147961 | COX-2-IN-23 | Inhibitor | / | Unkown |
| HY-147962 | AChE/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-147963 | COX-2-IN-24 | Inhibitor | / | Unkown |
| HY-149269 | COX-2-IN-30 | Inhibitor | / | Unkown |
| HY-149270 | COX-2-IN-31 | Inhibitor | / | Unkown |
| HY-149299 | PYZ18 | Inhibitor | / | Unkown |
| HY-149351 | NF-κB-IN-10 | Inhibitor | / | Unkown |
| HY-149355 | COX-2-IN-33 | / | Unkown | |
| HY-15029S2 | (±)-Naproxen-13C,d3 | / | Unkown | |
| HY-15036B | Diclofenac deanol | Inhibitor | / | Unkown |
| HY-15037S | Diclofenac-13C6 sodium heminonahydrate | / | Unkown | |
| HY-150548 | COX-2/15-LOX-IN-1 | Inhibitor | / | Unkown |
| HY-150550 | COX-2-IN-26 | Inhibitor | / | Unkown |
| HY-150551 | COX-2-IN-27 | Inhibitor | / | Unkown |
| HY-150553 | COX-2-IN-28 | Inhibitor | / | Unkown |
| HY-150685 | Topo I/COX-2-IN-1 | / | Unkown | |
| HY-150721 | COX-2-IN-29 | Inhibitor | / | Unkown |
| HY-150755 | Topo I/COX-2-IN-2 | / | Unkown | |
| HY-151173 | XO/COX/LOX-IN-1 | Inhibitor | / | Unkown |
| HY-15123S | (S)-Flurbiprofen-d3 | Inhibitor | / | Unkown |
| HY-151428 | Antitumor agent-78 | / | Unkown | |
| HY-151429 | Antitumor agent-77 | / | Unkown | |
| HY-151921 | Anti-inflammatory agent 33 | Inhibitor | / | Unkown |
| HY-152120 | (±)-Aiphanol | Inhibitor | / | Unkown |
| HY-15321S1 | Etoricoxib-13C,d3 | Inhibitor | / | Unkown |
| HY-153762 | COX-2-IN-32 | Inhibitor | / | Unkown |
| HY-153980 | K-80001 | Inhibitor | / | Unkown |
| HY-155133 | COX-2-IN-34 | Inhibitor | 98.87% | Unkown |
| HY-155159 | COX-2/15-LOX-IN-2 | Inhibitor | / | Unkown |
| HY-155160 | COX-2/15-LOX-IN-3 | Inhibitor | / | Unkown |
| HY-155161 | COX-2/15-LOX-IN-4 | Inhibitor | / | Unkown |
| HY-155764 | COX-1/2-IN-4 | Inhibitor | / | Unkown |
| HY-155780 | Anti-inflammatory agent 52 | Inhibitor | / | Unkown |
| HY-155781 | Anti-inflammatory agent 53 | Inhibitor | / | Unkown |
| HY-155997 | Anti-inflammatory agent 56 | Inhibitor | / | Unkown |
| HY-156254 | COX-2-IN-35 | Inhibitor | / | Unkown |
| HY-159158 | COX-1/2-IN-8 | Inhibitor | / | Unkown |
| HY-159169 | 5-LOX/sEH-IN-1 | Inhibitor | / | Unkown |
| HY-159516 | Sabialimon P | Inhibitor | / | Unkown |
| HY-159562 | COX-2-IN-46 | Inhibitor | / | Unkown |
| HY-159564 | iNOS/COX-2-IN-3 | Inhibitor | / | Unkown |
| HY-160184 | COX-1-IN-5 | Inhibitor | / | Unkown |
| HY-161147 | COX-2-IN-37 | Inhibitor | / | Unkown |
| HY-161266 | COX-2/NLRP3-IN-1 | Inhibitor | / | Unkown |
| HY-161294 | COX-2-IN-41 | Inhibitor | / | Unkown |
| HY-161513 | iNOS/COX-2-IN-1 | Inhibitor | / | Unkown |
| HY-161862 | COX-2-IN-44 | Inhibitor | / | Unkown |
| HY-161994 | COX-2-IN-47 | Inhibitor | / | Unkown |
| HY-162166 | COX-2/15-LOX/mPGES1-IN-1 | Inhibitor | / | Unkown |
| HY-162167 | COX-1-IN-1 | Inhibitor | / | Unkown |
| HY-162168 | Anti-inflammatory agent 71 | Inhibitor | / | Unkown |
| HY-162173 | WYZ90 | Inhibitor | / | Unkown |
| HY-162228 | VI-60 | Inhibitor | / | Unkown |
| HY-162244 | COX-2-IN-40 | Inhibitor | / | Unkown |
| HY-162385 | COX-2-IN-42 | Inhibitor | / | Unkown |
| HY-162425 | Anti-inflammatory agent 78 | Inhibitor | / | Unkown |
| HY-162523 | hMAO-B-IN-8 | Inhibitor | / | Unkown |
| HY-163116 | Anti-inflammatory agent 67 | Inhibitor | / | Unkown |
| HY-163117 | Anti-inflammatory agent 68 | Inhibitor | / | Unkown |
| HY-163187 | COX-2/LOX-IN-1 | Inhibitor | / | Unkown |
| HY-163188 | COX-2/LOX-IN-2 | Inhibitor | / | Unkown |
| HY-163355 | COX-2/15-LOX-IN-5 | Inhibitor | / | Unkown |
| HY-163509 | COX-2-IN-43 | / | Unkown | |
| HY-163888 | NO-IN-1 | Inhibitor | / | Unkown |
| HY-165027 | DL-1′-Acetoxychavicol acetate | Inhibitor | 98.82% | Unkown |
| HY-165386 | TU-100 | Inhibitor | / | Unkown |
| HY-165394 | Melafolone | Inhibitor | / | Unkown |
| HY-165587 | BM-573 | Modulator | / | Unkown |
| HY-168070 | COX-2-IN-48 | Inhibitor | / | Unkown |
| HY-168340 | COX-2/15-LOX-IN-6 | Inhibitor | / | Unkown |
| HY-168655 | EGFR/VEGFR2-IN-3 | / | Unkown | |
| HY-168888 | COX-2-IN-52 | Inhibitor | / | Unkown |
| HY-169103 | Neuroprotective agent 5 | Inhibitor | / | Unkown |
| HY-169167 | COX-2-IN-49 | Inhibitor | / | Unkown |
| HY-169215 | Anti-inflammatory agent 93 | / | Unkown | |
| HY-170585 | COX-2-IN-51 | Inhibitor | / | Unkown |
| HY-170836 | NLRP3-IN-69 | Inhibitor | / | Unkown |
| HY-170932 | EGFR/COX-2-IN-1 | / | Unkown | |
| HY-170938 | AChE-IN-82 | Inhibitor | / | Unkown |
| HY-171251 | RGS10 modulator-1 | Modulator | / | Unkown |
| HY-171992 | COX-2-IN-55 | 99.20% | Unkown | |
| HY-172619 | BS-153 | Inhibitor | / | Unkown |
| HY-172790 | Cbz-(S,S)-Pro-Pro-allyl | Inhibitor | / | Unkown |
| HY-173115 | 15-LOX-IN-2 | / | Unkown | |
| HY-173487 | COX-2-IN-53 | Inhibitor | / | Unkown |
| HY-173518 | SIN 14 | / | Unkown | |
| HY-17372S | Rofecoxib-d5 | Inhibitor | / | Unkown |
| HY-174159 | COX-2-IN-54 | Inhibitor | / | Unkown |
| HY-174260 | Neuroprotective agent 11 | / | Unkown | |
| HY-17474AS | Parecoxib-d5 sodium | Inhibitor | / | Unkown |
| HY-17474S | Parecoxib-d3 | Inhibitor | / | Unkown |
| HY-17509S | Deracoxib-d3 | / | Unkown | |
| HY-175643 | COX-2-IN-58 | Inhibitor | / | Unkown |
| HY-175698 | Ferroptosis inducer-9 | / | Unkown | |
| HY-175970 | MLS000099089 | Inhibitor | / | Unkown |
| HY-177319 | COX-2-IN-56 | Inhibitor | / | Unkown |
| HY-178440 | EGFR/COX-2-IN-2 | / | Unkown | |
| HY-179021 | COX-2/15-LOX-IN-7 | Inhibitor | / | Unkown |
| HY-179125 | COX-2-IN-59 | / | Unkown | |
| HY-179142 | COX-2-IN-60 | Inhibitor | / | Unkown |
| HY-179246 | CXT29 | / | Unkown | |
| HY-179363 | BChE-IN-46 | Inhibitor | / | Unkown |
| HY-179439 | Multi-kinase-IN-8 | / | Unkown | |
| HY-179485 | EGFR/VEGFR2-IN-10 | / | Unkown | |
| HY-179488 | (±)8(9)-EET | / | Unkown | |
| HY-179700 | COX-2-IN-61 | Inhibitor | / | Unkown |
| HY-180291 | Anti-inflammatory agent 109 | Inhibitor | / | Unkown |
| HY-180541 | EGFR-IN-190 | / | Unkown | |
| HY-180800 | Anti-inflammatory agent 110 | / | Unkown | |
| HY-180822 | COX-2-IN-63 | Inhibitor | / | Unkown |
| HY-180829 | HDAC6-IN-71 | Inhibitor | / | Unkown |
| HY-180952 | Zaltoprofen sulfoxide | / | Unkown | |
| HY-181044 | COX-2/5-LOX-IN-6 | Inhibitor | / | Unkown |
| HY-181056 | EGFR/COX-2-IN-3 | Inhibitor | 99.76% | Unkown |
| HY-181061 | COX/5-LO-IN-2 | / | Unkown | |
| HY-181081 | CHNQD-03005 | Inhibitor | / | Unkown |
| HY-181123 | AS1-6 | Inhibitor | / | Unkown |
| HY-181144 | COX-2-IN-65 | Inhibitor | / | Unkown |
| HY-181155 | Anti-inflammatory agent 111 | Inhibitor | / | Unkown |
| HY-181156 | Anti-inflammatory agent 112 | Inhibitor | / | Unkown |
| HY-181163 | Caspase-3/7 activator 4 | / | Unkown | |
| HY-181235 | COX-2/Aromatase-IN-1 | Inhibitor | / | Unkown |
| HY-181236 | COX-2/Aromatase-IN-2 | Inhibitor | / | Unkown |
| HY-181273 | COX-2/5-LOX-IN-7 | Inhibitor | / | Unkown |
| HY-181612 | COX-2/CaV2.2-IN-1 | Inhibitor | / | Unkown |
| HY-181766 | EGFR/VEGFR2-IN-11 | / | Unkown | |
| HY-181926 | COX-2/HDAC6-IN-1 | / | Unkown | |
| HY-182064 | EGFR-IN-206 | / | Unkown | |
| HY-182282 | PI3K/AKT-IN-6 | Inhibitor | / | Unkown |
| HY-182291 | COX-1/2-IN-11 | Inhibitor | / | Unkown |
| HY-182610 | ISP-VT | Inhibitor | / | Unkown |
| HY-182777 | HDAC6-IN-80 | Inhibitor | / | Unkown |
| HY-182778 | Anti-inflammatory agent 114 | Inhibitor | / | Unkown |
| HY-182779 | JNUTS013 | Inhibitor | / | Unkown |
| HY-182899 | DPAP | / | Unkown | |
| HY-183044 | SIRT1 activator 4 | Activator | / | Unkown |
| HY-183149 | BPN-37440 | Inhibitor | / | Unkown |
| HY-183187 | 4H-Chromen-4-one-o-carborane | / | Unkown | |
| HY-183188 | 7-Methoxy-4H-chromen-4-one-o-carborane | / | Unkown | |
| HY-183288 | COX-2-IN-66 | Inhibitor | / | Unkown |
| HY-183357 | GABAAR/5-HT2AR modulator-1 | / | Unkown | |
| HY-183673 | COX-1/2-IN-12 | Inhibitor | / | Unkown |
| HY-183764 | COX-2/5-LOX-IN-8 | Inhibitor | / | Unkown |
| HY-184292 | COX-2-IN-67 | Inhibitor | / | Unkown |
| HY-184324 | Anti-inflammatory agent 116 | Inhibitor | / | Unkown |
| HY-66005S3 | Acetaminophen-13C6 | Inhibitor | / | Unkown |
| HY-78131S1 | Ibuprofen-13C,d3 | / | Unkown | |
| HY-B0084S4 | Dienogest-13C,15N,d4 | Agonist | / | Unkown |
| HY-B0227S1 | Ketoprofen-d4 | 98.74% | Unkown | |
| HY-B0227S2 | Ketoprofen-13C,d3 | / | Unkown | |
| HY-B0253S1 | Piroxicam-d4 | Inhibitor | / | Unkown |
| HY-B0261S1 | Meloxicam-d3-1 | 98.0% | Unkown | |
| HY-B0335S | Tolfenamic acid-d4 | Inhibitor | / | Unkown |
| HY-B0335S1 | Tolfenamic acid-13C6 | Inhibitor | 99.7% | Unkown |
| HY-B0619S1 | Zaltoprofen-13C,d3 | Inhibitor | / | Unkown |
| HY-B0808S1 | Oxaprozin-d5 | Inhibitor | / | Unkown |
| HY-B1227S | Carprofen-d3 | Inhibitor | / | Unkown |
| HY-B1227S1 | Carprofen-13C,d3 | / | Unkown | |
| HY-B1773AR | Sodium propionate (Standard) | / | Unkown | |
| HY-B1773AS2 | Sodium propionate-13C2 | / | Unkown | |
| HY-B1888AS | Bromfenac-d4 sodium | Inhibitor | / | Unkown |
| HY-B2121R | 6-Methoxy-2-naphthoic acid (Standard) | Inhibitor | / | Unkown |
| HY-G0007S | Omeprazole sulfone-d3 | Control | / | Unkown |
| HY-G0007S1 | Omeprazole sulfone-13C,d3 | Control | / | Unkown |
| HY-N0041R | Ginsenoside Rb3 (Standard) | Inhibitor | / | Unkown |
| HY-N0043R | Ginsenoside Rd (Standard) | Inhibitor | / | Unkown |
| HY-N0222R | Avicularin (Standard) | / | Unkown | |
| HY-N0589S | Dehydrodiisoeugenol-d4 | / | Unkown | |
| HY-N0722A | (Z)-Neochlorogenic acid | / | Unkown | |
| HY-N0831R | Jaceosidin (Standard) | / | Unkown | |
| HY-N0864R | Macranthoidin B (Standard) | / | Unkown | |
| HY-N0904R | Ginsenoside C-K (Standard) | Inhibitor | / | Unkown |
| HY-N10009 | Cudraflavone B | / | Unkown | |
| HY-N11624 | Axinelline A | Inhibitor | / | Unkown |
| HY-N11784 | Triptolidenol | / | Unkown | |
| HY-N11880 | 2-O-Sinapoyl makisterone A | Inhibitor | / | Unkown |
| HY-N12708 | 23-O-β-D-Glucopyranosyl-20-isoveratramine | / | Unkown | |
| HY-N13040 | Isoscoparin-7-O-glucoside | Inhibitor | / | Unkown |
| HY-N1326 | Santamarine | 98.85% | Unkown | |
| HY-N1380S | Guaiacol-d7 | / | Unkown | |
| HY-N1380S2 | Guaiacol-13C6 | / | Unkown | |
| HY-N1380S3 | Guaiacol-d4 | / | Unkown | |
| HY-N1380S4 | Guaiacol-d4-1 | / | Unkown | |
| HY-N1474R | Picfeltarraenin IA (Standard) | Inhibitor | / | Unkown |
| HY-N15657 | Geiparvarin | / | Unkown | |
| HY-N16481 | Parameritannin A-1 | Inhibitor | / | Unkown |
| HY-N16482 | Cassiatannin A | Inhibitor | / | Unkown |
| HY-N16527 | 7-O-Galloyl-D-sedoheptulose | Inhibitor | / | Unkown |
| HY-N16849 | Myristinin A | Inhibitor | / | Unkown |
| HY-N16865 | Myristinin B/C | Inhibitor | / | Unkown |
| HY-N16881 | Andrographidine E | Inhibitor | / | Unkown |
| HY-N17131 | 24-O-Acetyllycoclavanol | Inhibitor | / | Unkown |
| HY-N17632 | Moracin G | / | Unkown | |
| HY-N17736 | Chikusetsusaponin IVa methyl ester | / | Unkown | |
| HY-N17783A | Sanleng acid | / | Unkown | |
| HY-N18001 | Plantanone A | Inhibitor | / | Unkown |
| HY-N18218 | Speranskoside | Inhibitor | / | Unkown |
| HY-N19215 | Arnicolide B | Inhibitor | / | Unkown |
| HY-N19847 | LYRM03 | Inhibitor | / | Unkown |
| HY-N19877 | Neokadsuranic acid B | / | Unkown | |
| HY-N2007S | Veratric acid-d6 | Inhibitor | / | Unkown |
| HY-N2266 | Benzoylgomisin O | Inhibitor | / | Unkown |
| HY-N2599 | Taraxerol acetate | 98.0% | Unkown | |
| HY-N3364 | Lucidone | Inhibitor | / | Unkown |
| HY-N3480 | Isogosferol | / | Unkown | |
| HY-N3716 | Dehydroglyasperin D | Inhibitor | / | Unkown |
| HY-N3848 | Ermanin | Inhibitor | 99.47% | Unkown |
| HY-N3866 | Esculentic acid | Inhibitor | / | Unkown |
| HY-N3891 | Fargesone A | Agonist | / | Unkown |
| HY-N4044 | Hirsutanonol | Inhibitor | / | Unkown |
| HY-N8641 | Kadsulignan N | Inhibitor | / | Unkown |
| HY-N8936 | Narchinol B | / | Unkown | |
| HY-P10710 | BMP-4 (15-24) | Inhibitor | / | Unkown |
| HY-P11646 | Brazzein | Inhibitor | / | Unkown |
| HY-W010066R | 3,4-Dihydroxyphenylglycol (Standard) | Inhibitor | / | Unkown |
| HY-W012126R | 2,6-Dichlorodiphenylamine (Standard) | Inhibitor | / | Unkown |
| HY-W015007S | Metyrosine-13C9,15N,d7 | Inhibitor | / | Unkown |
| HY-W032938 | COX-1-IN-4 | Inhibitor | / | Unkown |
| HY-W040045R | Callistephin chloride (Standard) | Inhibitor | / | Unkown |
| HY-W676872 | Dihydroflavokawin B | Inhibitor | / | Unkown |
| HY-W707656 | Aspirin-d7 | / | Unkown | |
| HY-W709448 | Oxaprozin-d10 | / | Unkown | |
| HY-W738273 | Veratric acid-13C | / | Unkown | |
| HY-W745860 | Hexahydrocurcumin-d6 | / | Unkown | |
| HY-W753345 | 2,6-Dichlorodiphenylamine-13C6 | / | Unkown | |
| HY-W753956 | Iminostilbene-d10 | / | Unkown | |
| HY-W777079 | Valdecoxib-13C2,15N | / | Unkown | |
| HY-W778002 | (S)-(+)-Ketoprofen-13C,d3 | / | Unkown | |
| HY-W995241 | BPD | Inhibitor | / | Unkown |
| HY-Y1100S | Cyclopropylmethyl bromide-d4 | 97.2% | Unkown | |
| HY-Y1100S1 | Cyclopropylmethyl bromide-d3 | / | Unkown | |
| HY-103388 | NCX 466 | Inhibitor | / | Unkown |
| HY-105028A | Tenidap sodium | Inhibitor | / | Unkown |
| HY-105304 | COX-2-IN-36 | Inhibitor | / | Unkown |
| HY-108162 | Ataquimast free base | Inhibitor | / | Unkown |
| HY-113807 | ZLJ-6 | Inhibitor | / | Unkown |
| HY-116115 | 17-Oxo-7(Z),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid | / | Unkown | |
| HY-118691 | BMS-347070 | Inhibitor | / | Unkown |
| HY-120232 | ABT-963 | Inhibitor | / | Unkown |
| HY-124432 | CRT0093964 | Inhibitor | / | Unkown |
| HY-134138 | Indomethacin N-octyl amide | Inhibitor | / | Unkown |
| HY-138128 | Acetaminophen mercapturate | / | Unkown | |
| HY-138164 | Cafestol palmitate | / | Unkown | |
| HY-139129 | N-(3-Pyridyl)indomethacinamide | Inhibitor | / | Unkown |
| HY-14397S2 | Indometacin-d7 | Inhibitor | / | Unkown |
| HY-14397S3 | Indomethacin-13C6 | Inhibitor | / | Unkown |
| HY-14670S | Firocoxib-d4 | Inhibitor | / | Unkown |
| HY-149460 | Harmaline analog | Inhibitor | / | Unkown |
| HY-15030S1 | Naproxen-d3 | 99.14% | Unkown | |
| HY-157578 | COX-2-IN-38 | Inhibitor | / | Unkown |
| HY-157583 | COX-2-IN-39 | Inhibitor | / | Unkown |
| HY-160121 | Patrinoside aglucone | Inhibitor | / | Unkown |
| HY-160431 | 8(9)-EET | / | Unkown | |
| HY-162044 | COX-1/2-IN-6 | Inhibitor | / | Unkown |
| HY-167630 | Ketoprofen sodium | Inhibitor | / | Unkown |
| HY-167632 | meso-Zeaxanthin | 93.09% | Unkown | |
| HY-171470 | RS-57067 | Inhibitor | / | Unkown |
| HY-173388 | TLR4-IN-2 | Inhibitor | / | Unkown |
| HY-173485 | SARS-CoV-2 Mpro-IN-41 | Inhibitor | / | Unkown |
| HY-17474S1 | Parecoxib-d5 | Inhibitor | / | Unkown |
| HY-175062 | 8-iso Prostaglandin F2α ethanolamide | / | Unkown | |
| HY-175637 | COX-2-IN-57 | Inhibitor | / | Unkown |
| HY-177440 | T26A | / | Unkown | |
| HY-180203 | COX-1/2-IN-10 | Inhibitor | / | Unkown |
| HY-19217 | Thioflosulide | Inhibitor | / | Unkown |
| HY-66005S5 | Acetaminophen-d5 | Inhibitor | / | Unkown |
| HY-B0227S3 | Ketoprofen-13C6 | Inhibitor | / | Unkown |
| HY-B0253A | Piroxicam olamine | Inhibitor | / | Unkown |
| HY-B0360S | Rebamipide-d4 | Activator | 99.0% | Unkown |
| HY-B0363S | Nimesulide-d5 | Inhibitor | / | Unkown |
| HY-B0363S1 | Nimesulide-13C6 | Inhibitor | / | Unkown |
| HY-B0580D | Ketorolac hydrochloride | / | Unkown | |
| HY-B0580S1 | Ketorolac-d4 | Inhibitor | / | Unkown |
| HY-B0580S2 | Ketorolac-13C6 | / | Unkown | |
| HY-B0760S1 | Fenofibric acid-13C8 | / | Unkown | |
| HY-B0760S2 | Fenofibric acid-d4 | / | Unkown | |
| HY-B1138S | Fenbufen-d9 | Inhibitor | / | Unkown |
| HY-B1773AS1 | Sodium propionate-13C-1 | / | Unkown | |
| HY-B1799S | Tolmetin-d3 | / | Unkown | |
| HY-B2137S | S-(+)-Ketoprofen-d3 | Inhibitor | / | Unkown |
| HY-D2297 | AIE-GA | / | Unkown | |
| HY-N0346 | 4-Methoxycinnamic acid ethyl ester | 98.72% | Unkown | |
| HY-N0493R | Pectolinarigenin (Standard) | / | Unkown | |
| HY-N0589R | Dehydrodiisoeugenol (Standard) | / | Unkown | |
| HY-N0631R | Cornuside (Standard) | Inhibitor | / | Unkown |
| HY-N0894R | Octahydrocurcumin (Standard) | / | Unkown | |
| HY-N10133 | Licoflavanone | / | Unkown | |
| HY-N13944 | Argyrin F | Inducer | / | Unkown |
| HY-N15272 | Artocarpesin | Inhibitor | / | Unkown |
| HY-N15347 | Talaromyketide B | Inhibitor | / | Unkown |
| HY-N15378 | β-Carotene-15,15'-epoxide | / | Unkown | |
| HY-N3989 | Haplopine | 99.49% | Unkown | |
| HY-N8012 | Multinoside A | Inhibitor | / | Unkown |
| HY-N9086A | (rac)-Poriol | Ligand | / | Unkown |
| HY-N9541 | Chaetoglobosin Vb | / | Unkown | |
| HY-RS16902 | Ptgs2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20181 | mt-Co2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23344 | Ptgs2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26685 | mt-Co2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00083 | Flosulide | Inhibitor | / | Unkown |
| HY-W026426 | 4,5,6,7-Tetrahydro-1,2-benzoxazole-3-carboxylic acid | Inhibitor | 98.06% | Unkown |
| HY-W162983 | 3,4-Diphenyl-5H-furan-2-one | Inhibitor | / | Unkown |
| HY-W347202 | N-Caffeoyl serotonin | Inhibitor | / | Unkown |
| HY-W557590 | Nabumetone alcohol | / | Unkown | |
| HY-W587743 | N1-Acetyl-5-methoxykynuramine hydrochloride | Inhibitor | / | Unkown |
| HY-W654009 | Loxoprofen-d3 | Inhibitor | / | Unkown |
| HY-W703540 | Deracoxib-d4 | / | Unkown | |
| HY-W792524 | Methosulide | Inhibitor | / | Unkown |
| HY-Z4707 | Etoricoxib N1'-oxide | 99.97% | Unkown | |
| HY-Z7640 | 4-Desmethyl-2-methyl celecoxib | Inhibitor | / | Unkown |
| HY-101655 | COX-2-IN-2 | Inhibitor | 99.53% | Unkown |
| HY-U00275 | COX-2-IN-1 | Inhibitor | / | Unkown |
| HY-U00197 | Tilmacoxib | Inhibitor | 99.0% | Unkown |
| HY-U00239 | SC58451 | Inhibitor | / | Unkown |